Ventricular Fibrillation
📧 Sign up to get email alerts when something new happens for Ventricular Fibrillation.
Sign up freeTop drugs studied for this disease
-
FDA approval · 2024-09-11FDA Approved: AMIODARONE HYDROCHLORIDE — Original Application (Slate Run Pharmaceuticals)
FDA approved the original application for Amiodarone hydrochloride (Slate Run Pharmaceuticals) as a generic antiarrhythmic agent.
-
CLINICAL_TRIALS trial_result · 2024-05-30Clinical Trial Update: Cardiopulmonary Resuscitation Performance of Professional Rescuers With a New Defibrillation Algorithm
A completed clinical trial evaluating CPR performance of professional rescuers using a new defibrillation algorithm.
-
CLINICAL_TRIALS trial_result · 2024-05-09Clinical Trial Update: Acute Feasibility Investigation of a New S-ICD Electrode [NA]
A feasibility study of a new subcutaneous ICD electrode for ventricular fibrillation has completed and results were posted on 2024-05-09.
-
CLINICAL_TRIALS trial_result · 2024-01-19Clinical Trial Update: Cardiac Sympathetic Denervation for Prevention of Ventricular Tachyarrhythmias [Phase 3]
Phase 3 trial evaluating cardiac sympathetic denervation to prevent ventricular tachyarrhythmias in patients at risk of sudden cardiac death…
-
FDA approval · 2023-09-11FDA Approved: SOTALOL HYDROCHLORIDE — Supplemental Application (Apotex Corp.)
FDA approves Apotex Corp.'s supplemental application for sotalol hydrochloride, enabling a generic version of the antiarrhythmic for clinica…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2021-11-22Clinical Trial Update: Advanced Reperfusion Strategies for Refractory Cardiac Arrest [NA]
Clinical trial on advanced reperfusion strategies for refractory cardiac arrest has terminated; results posted in 2021.
-
CLINICAL_TRIALS trial_result · 2021-10-19Clinical Trial Update: GANGlion Stellate Block for Treatment of Electric storRm (GANGSTER Trial) [Phase 3]
Phase 3 clinical trial update for GANGlion Stellate Block therapy targeting ventricular arrhythmias, including ventricular tachycardia and r…
-
CLINICAL_TRIALS trial_result · 2021-07-01Clinical Trial Update: Septal - Success Rate and Clinical Outcome of Septal Implant of Ventricular Defibrillation Lead [NA]
This clinical trial update reports completion and posted results for a Septal implant of a ventricular defibrillation lead, focusing on outc…
-
CLINICAL_TRIALS trial_result · 2021-02-02Clinical Trial Update: Evaluation of the iD-SystemTM, One-Handed Disposable Internal Defibrillation System. [NA]
A completed clinical trial evaluating the iD-System One-Handed Disposable Internal Defibrillation System is reported, with results posted in…
-
CLINICAL_TRIALS trial_result · 2021-01-27Clinical Trial Update: ACCESS to the Cardiac Cath Lab in Patients Without STEMI Resuscitated From Out-of-hospital VT/VF Cardiac Arrest [NA]
A terminated clinical trial evaluating access to the cardiac cath lab for patients without STEMI resuscitated from out-of-hospital ventricul…
-
CLINICAL_TRIALS trial_result · 2021-01-20Clinical Trial Update: Vest Prevention of Early Sudden Death Trial and VEST Registry [NA]
Clinical trial update for the Vest Prevention of Early Sudden Death Trial and VEST Registry, completed with results posted in 2021.
-
CLINICAL_TRIALS trial_result · 2021-01-08Clinical Trial Update: Understanding Outcomes With the EMBLEM™ S-ICD in Primary Prevention Patients With Low Ejection Fraction [NA]
Boston Scientific's EMBLEM S-ICD was studied for primary prevention in patients with low ejection fraction, and the trial results were poste…
-
FDA approval · 2020-07-21FDA Approved: AMIODARONE HYDROCHLORIDE — Original Application (Unichem Pharmaceuticals (USA), Inc.)
The FDA approved the Original Application for Amiodarone Hydrochloride from Unichem Pharmaceuticals (USA), Inc., confirming regulatory appro…
-
FDA approval · 2020-07-15FDA Approved: AMIODARONE HYDROCHLORIDE — Supplemental Application (Chartwell RX, LLC)
FDA approved a supplemental application for amiodarone hydrochloride (Chartwell RX, LLC).
-
FDA approval · 2020-06-23FDA Approved: AMIODARONE HYDROCHLORIDE — Supplemental Application (Gland Pharma Limited)
The FDA approved a supplemental application for amiodarone hydrochloride from Gland Pharma Limited.
-
FDA approval · 2020-06-23FDA Approved: AMIODARONE HYDROCHLORIDE — Supplemental Application (Sun Pharmaceutical Industries, Inc.)
FDA approved a supplemental application for amiodarone hydrochloride from Sun Pharmaceutical Industries, Inc.
-
FDA approval · 2020-06-23FDA Approved: AMIODARONE HYDROCHLORIDE — Supplemental Application (Sun Pharmaceutical Industries, Inc.)
FDA approved a supplemental application for amiodarone hydrochloride from Sun Pharmaceutical Industries, Inc. The approval relates to change…
-
FDA approval · 2020-05-04FDA Approved: AMIODARONE HYDROCHLORIDE — Supplemental Application (Fresenius Kabi USA, LLC)
The FDA approved a supplemental application for amiodarone hydrochloride from Fresenius Kabi USA, LLC.
-
FDA approval · 2019-11-21FDA Approved: AMIODARONE HYDROCHLORIDE — Supplemental Application (Dr. Reddy's Labratories Inc.)
The FDA approved a supplemental application for Amiodarone hydrochloride from Dr. Reddy's Laboratories, enabling the generic product's marke…
-
FDA approval · 2019-10-29FDA Approved: AMIODARONE HYDROCHLORIDE — Supplemental Application (Zydus Lifesciences Limited)
FDA approved a supplemental application for Amiodarone Hydrochloride from Zydus Lifesciences Limited.
-
FDA approval · 2019-08-15FDA Approved: AMIODARONE HYDROCHLORIDE — Supplemental Application (Sun Pharmaceutical Industries, Inc.)
The FDA approved Sun Pharmaceutical Industries, Inc.'s supplemental application for amiodarone hydrochloride, granting approval for a generi…
-
CLINICAL_TRIALS trial_result · 2019-02-27Clinical Trial Update: Evaluation of the Efficacy and Safety of Nifekalant Hydrochloride (NIF) Injection. [Phase 4]
Phase 4 clinical trial evaluating the efficacy and safety of nifekalant hydrochloride injection for ventricular tachycardia and ventricular …
-
CLINICAL_TRIALS trial_result · 2019-02-04Clinical Trial Update: Septal Positioning of Ventricular Implanted Cardioverter Defibrillator (ICD) Leads [NA]
Clinical trial update on septal positioning of ventricular ICD leads by Abbott Medical Devices. The study involved ventricular tachycardia a…
-
CLINICAL_TRIALS trial_result · 2019-02-04Clinical Trial Update: 50/50% Tilt and Tuned Defibrillation Waveform [NA]
A completed clinical trial sponsored by Abbott Medical Devices evaluated a 50/50% tilt and tuned defibrillation waveform for defibrillation …
-
CLINICAL_TRIALS trial_result · 2019-02-04Clinical Trial Update: DAVID II (Dual Chamber and VVI Implantable Defibrillator (DAVID) Trial II) [NA]
ClinicalTrials.gov entry reports the completed DAVID II trial evaluating dual-chamber and VVI implantable defibrillators. The sponsor is Abb…